FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101168 [Registered on: 14/01/2026] Trial Registered Prospectively
Last Modified On: 14/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   How Different Intracanal Medications Affect Pain After Root Canal Treatment in Diabetic Patients 
Scientific Title of Study   Effect of Various Intracanal Medicaments on the Incidence and Intensity of Post Operative Pain in Patients with Diabetes Mellitus : A Randomized Controlled Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SHREYA RASHI 
Designation  POST GRADUATE STUDENT  
Affiliation  SGT DENTAL COLLEGE 
Address  Room no 204, b block, faculty of dental science, dept of cons endo, first floor, SGT dental college, gurugram
SGT UNIVERSITY, BUDHERA,GURGAON
Gurgaon
HARYANA
122505
India 
Phone  9667802892  
Fax    
Email  rashishreya10@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Mamta Singla  
Designation  Professor  
Affiliation  SGT DENTAL COLLEGE 
Address  Room no 204, B block, faculty of dental science, dept of cons endo, first floor, SGT dental college, gurugram
SGT UNIVERSITY, BUDHERA,GURGAON
Gurgaon
HARYANA
122505
India 
Phone  9891381349  
Fax    
Email  mamta.singla@sgtuniversity.org  
 
Details of Contact Person
Public Query
 
Name  SHREYA RASHI 
Designation  POST GRADUATE STUDENT  
Affiliation  SGT DENTAL COLLEGE 
Address  Room no 204, b block, faculty of dental science, dept of cons endo, first floor, SGT dental college, gurugram
SGT UNIVERSITY, BUDHERA,GURGAON
Gurgaon
HARYANA
122505
India 
Phone  9667802892  
Fax    
Email  rashishreya10@gmail.com  
 
Source of Monetary or Material Support  
SGT University, Faculty of Dental Sciences, Department of Conservative dentistry and endodontics  
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHREYA RASHI  SGT DENTAL COLLEGE  ROOM 204, DEPARTMENT OF CONSERVATIVE DENTISTRY AND ENDODONTICS, SGT DENTAL COLLEGE, BUDHERA, GURGAON, HARYANA
Gurgaon
HARYANA 
9667802892

rashishreya10@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC-SGTDCHRI   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications, (2) ICD-10 Condition: K049||Other and unspecified diseases ofpulp and periapical tissues,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intracanal medicament   1. Dexamethasone (Dexona 4 mg in the form of powder mixed with saline to form a moderately thick paste) 2. Diclofenac (Diclom 50mg in the form of powder mixed with Saline to form a moderately thick paste) 3.Triple Antibiotic Paste (minocycline 100mg, metronidazole 400mg, Ciproflaxacin 500mg are taken in the form of powder and mixed in the ratio 1:1:1 , then with 0.3 ml of Saline to form a moderately thick paste 
Comparator Agent  Intracanal medicament   Calcium hydroxide powder mixed with Saline in the ratio 1:1 to form a moderately thick paste . This medicament will be placed inside the canal using rotary file in the counterclockwise direction  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with controlled diabetes [HbA1C levels (6-7.65%)]
Mature mandibular permanent teeth with symptomatic irreversible pulpitis.
Teeth having sufficient tooth structure for adequate isolation.
No history of previous endodontic therapy.
No history of trauma to the involved tooth.
Age criteria: between 18 to 60 years.
Ability to understand and provide informed consent
 
 
ExclusionCriteria 
Details  immunocompromised patients, pregnant, lactating females.
Patients who have a positive history of analgesic intake within past 3 days.
Patients who have a positive history of antibiotics intake in the last month.
• Patients with known history of allergy to the drugs in study.
Patients with radiographic evidence periapical pathology.
Periodontally compromised teeth
Calcified roots.
Patients with known history of peptic ulcers or gastrointestinal bleeding.
Neurologic patients.
• Psychiatric patients who are not able to rate the pain.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
pain levels measured and compared  4hrs, 8hrs, 12hrs, 24hrs, 48hrs 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   24/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The aim of present randomized double blinded clinical trial is to evaluate the incidence and intensity of postoperative pain in patients with diabetes following root canal treatment for teeth with Symptomatic Irreversible Pulpitis in relation to the effects of Calcium Hydroxide, Dexamethasone, Diclofenac, Triple Antibiotic Paste used as intracanal medicament.
                                                OBJECTIVES
1. To evaluate the effect of Diclofenac as an intracanal medicament on the postoperative pain after endodontic treatment of the teeth with irreversibly inflamed pulps.
2. To evaluate the effect of Dexamethasone as an intracanal medicament on the postoperative pain after endodontic treatment of the teeth with irreversibly inflamed pulps.
3. To evaluate the effect of Triple Antibiotic Paste as an intracanal medicament on the postoperative pain after endodontic treatment of the teeth with irreversibly inflamed pulps.
4. To evaluate the effect of Calcium Hydroxide as an intracanal medicament on the postoperative pain after endodontic treatment of the teeth with irreversibly inflamed pulps.
5. To evaluate the incidence and intensity of the post operative pain in each case.
6. To compare the efficacy of the above stated intracanal medicament with each other and to determine the drug of choice among these to best facilitate post operative pain in patients with diabetes.

  MATERIALS AND METHODOLOGY
MATERIALS AND ARMAMENTARIUM
Diclofenac - (Diclom 50mg)
 Dexamethasone –(Dexona 4mg )
Triple Antibiotic Paste ( Minocycline 100mg, Metronidazole 400mg, Ciprofloxacin 500 mg in the ratio 1:1:1)
 Calcium Hydroxide
Local anaesthesia (2% lidocaine with adrenaline 1:80,000)
 24gauge needle and syringe
Electric pulp tester
Endo ice
Rubber dam kit
Air rotor handpiece
 Large round diamond point.
Tapered fissure diamond point
 Endo access burs
Endo-Z bur
 DG-16 endodontic probe
Hand files
Electronic apex locator
 Endomotor
Rotary files
30gauge trunatomy double side vented irrigation needles
Endoactivator
 2.5% sodium hypochlorite solution
 Normal saline
 EDTA
 Absorbent paper points
Gutta percha points
 Ah plus sealer
 Cavit

 
Close